Singapore markets closed

Universe Pharmaceuticals INC (UPC)

NasdaqGM - NasdaqGM Real-time price. Currency in USD
Add to watchlist
1.1658+0.0258 (+2.26%)
As of 10:24AM EDT. Market open.
Currency in USD

Valuation measures4

Market cap (intra-day) 4.68M
Enterprise value -17.52M
Trailing P/E N/A
Forward P/E N/A
PEG Ratio (5 yr expected) N/A
Price/sales (ttm)0.14
Price/book (mrq)0.10
Enterprise value/revenue -0.51
Enterprise value/EBITDA 1.69

Trading information

Stock price history

Beta (5Y monthly) 1.49
52-week change 3-63.87%
S&P500 52-week change 313.12%
52-week high 312.4800
52-week low 30.9100
50-day moving average 31.5233
200-day moving average 33.7069

Share statistics

Avg vol (3-month) 332.49k
Avg vol (10-day) 311.42k
Shares outstanding 53.62M
Implied shares outstanding 63.62M
Float 81.56M
% held by insiders 1N/A
% held by institutions 1N/A
Shares short (14 Sept 2023) 429.05k
Short ratio (14 Sept 2023) 44.07
Short % of float (14 Sept 2023) 41.88%
Short % of shares outstanding (14 Sept 2023) 40.80%
Shares short (prior month 14 Aug 2023) 470.83k

Dividends & splits

Forward annual dividend rate 4N/A
Forward annual dividend yield 4N/A
Trailing annual dividend rate 30.00
Trailing annual dividend yield 30.00%
5-year average dividend yield 4N/A
Payout ratio 40.00%
Dividend date 3N/A
Ex-dividend date 4N/A
Last split factor 21:6
Last split date 327 Jul 2023

Financial highlights

Fiscal year

Fiscal year ends 29 Sept 2022
Most-recent quarter (mrq)30 Mar 2023

Profitability

Profit margin -32.50%
Operating margin (ttm)-29.04%

Management effectiveness

Return on assets (ttm)-8.81%
Return on equity (ttm)-20.66%

Income statement

Revenue (ttm)34.41M
Revenue per share (ttm)9.49
Quarterly revenue growth (yoy)-23.70%
Gross profit (ttm)21.89M
EBITDA -9.49M
Net income avi to common (ttm)-11.18M
Diluted EPS (ttm)-2.9300
Quarterly earnings growth (yoy)N/A

Balance sheet

Total cash (mrq)26.27M
Total cash per share (mrq)7.25
Total debt (mrq)4.08M
Total debt/equity (mrq)8.65%
Current ratio (mrq)2.26
Book value per share (mrq)13.00

Cash flow statement

Operating cash flow (ttm)-2.63M
Levered free cash flow (ttm)3.99M